This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A team at Michigan State University has developed an AI model designed to detect rib fractures in children under three years old, with the ribcage being the most common fracture site in abused children. The model approached the capabilities of expert human readers on a set of 1,109 pediatric chest x-rays and could serve as a tool to help detect injuries due to physical abuse, noted lead author Jonathan Burkow, a doctoral student, and colleagues.
Some of the top "domains" of point-of-care ultrasound (POCUS) incorporate the technology into lung ultrasound applications, according to research published in the Journal of Radiology Nursing. A team led by the POCUS Certification Academy, part of Inteleos in Rockville, MD, published a list of the top 25 POCUS community-defined practice domains, dubbed “POCUS25.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT (LDCT) helps clinicians determine how to follow up better than rule-based protocols, researchers have found. A group led by Zixing Wang, MD, of Peking Union Medical College in Beijing, China, found that a tailored model had a 0% rate of delayed diagnosis of lung cancer at 12-month follow-up.
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT (LDCT) helps clinicians determine how to follow up better than rule-based protocols, researchers have found. A group led by Zixing Wang, MD, of Peking Union Medical College in Beijing, China, found that a tailored model had a 0% rate of delayed diagnosis of lung cancer at 12-month follow-up.
Autism spectrum disorder has yet to be linked to a single cause, due to the wide range of its symptoms and severity. However, a recent study suggests a promising new approach to finding answers, one that could lead to advances in the study of other neurological conditions.
Portable MRI developer Hyperfine has enrolled the first patients in a trial to test its Swoop system in Alzheimer’s disease patients undergoing amyloid-targeting therapy. The CARE PMR (Capturing ARIA Risk Equitably with Portable MR) observational study is designed to assess the clinical utility and workflow benefits of Swoop system. Imaging will be performed at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIAs) in Alzheimer’s patients.
milla1cf Wed, 04/17/2024 - 16:12 April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients on whether to proceed with lung cancer screening is fraught with confusion and lack of evidence-based information, and may actually be undermining the purpose for which it was created, Mount Sinai researchers say.
The Radiology Leadership Institute (RLI) announced its Impact in Leadership Award and Emerging Leader Scholarship recipients during the American College of Radiology (ACR) annual meeting in Washington, DC. The 2024 RLI Impact in Leadership Award recipient is Archie R. McGowan, MD, from Portsmouth Regional Hospital in New Hampshire. The award honors individuals whose participation in an RLI course or program was integral to the successful completion of specific projects or initiatives at their pr
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
milla1cf Wed, 04/17/2024 - 16:02 April 17, 2024 — Hyperfine, Inc. , a groundbreaking health technology company that has redefined brain imaging with the first FDA -cleared portable magnetic resonance ( MR ) brain imaging system— the Swoop system—announced that the first patients have been enrolled in the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) observational study.
The American College of Radiology (ACR) Economics and Health Policy Department has selected William Donovan, MD, as the 2024 recipient of its William T. Thorwarth Jr., MD award. Donovan received the award at ACR 2024, the college’s annual meeting. The award recognizes individuals who demonstrate outstanding contributions to the field of health policy and economics for radiology.
milla1cf Wed, 04/17/2024 - 16:08 April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI -driven MRI image acquisition enabling any MRI technician to consistently produce high quality scans for complex indications quickly, efficiently and affordably. Daniel joins Vista.ai at a pivotal time following FDA clearance and confirmatory early commercialization of the company’s initial product focused on Cardiac MRI (CMR).
Lumicell's Lumisight (pegulicianine) optical imaging agent has been approved by a new drug application (NDA) by the U.S. Food and Drug Administration (FDA). The FDA has also granted premarket approval for the company's LumiSystem, Lumicell's direct visualization system. Both Lumisight and LumiSystem previously received FDA Fast Track and Breakthrough Device designations.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
A novel ultrasound-launched targeted nanoparticle has been shown to universally destroy biofilms, target specific bacteria, administer antibiotics, and eliminate bacteria.
Blackford has entered a commercial partnership with Lucida Medical to integrate Lucida's prostate cancer MRI imaging software (Pi) into its AI platform. Pi is designed to help healthcare professionals work more quickly by automating laborious steps and increasing accuracy for MRI detection of clinically significant prostate cancer. The software has proven effective in supporting analysis of prostate MRIs in real-world applications across multiple healthcare settings, scanner types, and vendors,
These days, many medical imaging facilities are choosing to rent an imaging solution instead of purchasing one. But how do you know when it make more sense to rent than buy?
Medical technology trade association Advanced Medical Technology Association (AdvaMed) is urging Congress to pass a tax provision to change how small businesses deduct their research and development expenses. In a letter to Senate Majority Leader Chuck Schumer, AdvaMed President and CEO Scott Whitaker underscored the critical importance of passing such a provision.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas. Pixclara was developed by researchers at the University of California, San Francisco. The tracer reveals the activity of specific transporter proteins known as LAT1 and LAT2, which are highly active in brain regions with gliomas.
The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
As one of the largest consumers of raw materials and natural resources, the construction industry is under significant pressure to become more sustainable. The process sounds complex and can be. As construction management teams work to address ways to reduce costs, shore up labor shortages, and build more efficiently, they stand to see benefits including brand image, client satisfaction, and reduced energy costs.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
The key to successful AI implementation is to make sure your measure for AI success aligns with organizational goals. Listen to some AI strategy insights from Sunil Dadlani, EVP, Chief Information and Digital Transformation Officer and Chief Cyber Security Officer at Atlantic Health System as he explains overcoming the hype that comes with “tech toy syndrome” and how to align tech adoption with solutions for more than just one use case.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
299 
Let's personalize your content